Edwards Lifesciences

EWleader

Edwards Lifesciences is the global leader in transcatheter heart valve therapies, particularly TAVR, which has transformed treatment for aortic stenosis from open-heart surgery to a catheter-based procedure.

⇄ Compare

Produk & Pendapatan

Pangsa Pendapatan Produk

Komposisi Pendapatan ($6.4B)

Data statis (memuat keuangan langsung…)

Transcatheter Aortic Valve (60%)

Surgical Structural Heart (15%)

Critical Care (15%)

TMTT (10%)

Komposisi segmen dan pelanggan utama

Detail produk

TAVR (SAPIEN)60%

Transcatheter aortic valve replacement systems for heart valve disease

TMTT10%

Transcatheter mitral and tricuspid valve therapies in development

Surgical Structural Heart15%

Surgical heart valves and repair products

Critical Care15%

Hemodynamic monitoring and smart recovery technologies

Hubungan Rantai Pasok

Pesaing

Medtronic

CoreValve TAVR system

Dampak: Primary TAVR competitor

Abbott Laboratories

Structural heart portfolio

Dampak: Growing competitor in structural heart

Boston Scientific

ACURATE valve

Dampak: Emerging TAVR competitor

Konteks makro dan pasar

헬스케어Berita sektor

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Katalis mendatang

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Berita terkini

Memuat berita...

Analisis AI

Klik "Dapatkan Analisis AI" untuk analisis rantai pasok Edwards Lifesciences.

Info Perusahaan

Kantor Pusat

Irvine, California, USA

Didirikan

1958

Karyawan

20,000+

Situs Web

edwards.com

Gambaran umum sektor — 헬스케어

Berita sektor